Vyleesi is an English word starting with the letter V. With 2 example sentences you'll see exactly how it works in context.
Vyleesi in a sentence
Context around Vyleesi
- Average sentence length in these examples: 24.5 words
- Position in the sentence: 0 start, 2 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Vyleesi
- In this selection, "vyleesi" usually appears in the middle of the sentence. The average example has 24.5 words, and this corpus slice is mostly made up of statements.
- Around the word, approved stand out and add context to how "vyleesi" is used.
- Recognizable usage signals include fda approved vyleesi as a and respect to vyleesi which is. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "vyleesi" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with vyleesi
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
On June 21st, the FDA approved Vyleesi as a treatment for premenopausal women with acquired generalized, hypoactive sexual desire disorder. (20 words)
Regarding Palatin’s quarter and year ended June 30, 2019, certain operational and financial highlights include, with respect to Vyleesi, which is approved for female hypoactive sexual desire disorder. (29 words)
Regarding Palatin’s quarter and year ended June 30, 2019, certain operational and financial highlights include, with respect to Vyleesi, which is approved for female hypoactive sexual desire disorder. (29 words)
On June 21st, the FDA approved Vyleesi as a treatment for premenopausal women with acquired generalized, hypoactive sexual desire disorder. (20 words)
Example sentences (2)
On June 21st, the FDA approved Vyleesi as a treatment for premenopausal women with acquired generalized, hypoactive sexual desire disorder.
Regarding Palatin’s quarter and year ended June 30, 2019, certain operational and financial highlights include, with respect to Vyleesi, which is approved for female hypoactive sexual desire disorder.